Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.

Shin S, Kim TD, Jin F, van Deursen JM, Dehm SM, Tindall DJ, Grande JP, Munz JM, Vasmatzis G, Janknecht R.

Cancer Res. 2009 Oct 15;69(20):8102-10. doi: 10.1158/0008-5472.CAN-09-0941. Epub 2009 Sep 29.

PMID:
19789348
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.

Shin S, Oh S, An S, Janknecht R.

Oncol Rep. 2013 Jan;29(1):306-14. doi: 10.3892/or.2012.2079. Epub 2012 Oct 16.

PMID:
23076342
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

c-Jun has multiple enhancing activities in the novel cross talk between the androgen receptor and Ets variant gene 1 in prostate cancer.

Cai C, Hsieh CL, Shemshedini L.

Mol Cancer Res. 2007 Jul;5(7):725-35.

PMID:
17634427
[PubMed - indexed for MEDLINE]
Free Article
4.

ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion.

Cai C, Hsieh CL, Omwancha J, Zheng Z, Chen SY, Baert JL, Shemshedini L.

Mol Endocrinol. 2007 Aug;21(8):1835-46. Epub 2007 May 15.

PMID:
17505060
[PubMed - indexed for MEDLINE]
5.

Gum mastic inhibits the expression and function of the androgen receptor in prostate cancer cells.

He ML, Yuan HQ, Jiang AL, Gong AY, Chen WW, Zhang PJ, Young CY, Zhang JY.

Cancer. 2006 Jun 15;106(12):2547-55.

PMID:
16691616
[PubMed - indexed for MEDLINE]
Free Article
6.

Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer.

Gan L, Chen S, Wang Y, Watahiki A, Bohrer L, Sun Z, Wang Y, Huang H.

Cancer Res. 2009 Nov 1;69(21):8386-94. doi: 10.1158/0008-5472.CAN-09-1504. Epub 2009 Oct 13.

PMID:
19826044
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes.

Gao N, Zhang J, Rao MA, Case TC, Mirosevich J, Wang Y, Jin R, Gupta A, Rennie PS, Matusik RJ.

Mol Endocrinol. 2003 Aug;17(8):1484-507. Epub 2003 May 15.

PMID:
12750453
[PubMed - indexed for MEDLINE]
8.

Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR.

Shiota M, Yokomizo A, Tada Y, Inokuchi J, Tatsugami K, Kuroiwa K, Uchiumi T, Fujimoto N, Seki N, Naito S.

Mol Endocrinol. 2010 Jan;24(1):114-27. doi: 10.1210/me.2009-0302. Epub 2009 Nov 2.

PMID:
19884383
[PubMed - indexed for MEDLINE]
9.

Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours.

Dart DA, Spencer-Dene B, Gamble SC, Waxman J, Bevan CL.

Endocr Relat Cancer. 2009 Dec;16(4):1157-69. doi: 10.1677/ERC-09-0028. Epub 2009 Jul 27.

PMID:
19635783
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.

Yemelyanov A, Czwornog J, Gera L, Joshi S, Chatterton RT Jr, Budunova I.

Cancer Res. 2008 Jun 15;68(12):4763-73. doi: 10.1158/0008-5472.CAN-07-6104.

PMID:
18559523
[PubMed - indexed for MEDLINE]
Free Article
11.

Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes.

Dai Y, Ngo D, Jacob J, Forman LW, Faller DV.

Carcinogenesis. 2008 Sep;29(9):1725-33. doi: 10.1093/carcin/bgn117. Epub 2008 May 16.

PMID:
18487222
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.

Cherian MT, Wilson EM, Shapiro DJ.

J Biol Chem. 2012 Jul 6;287(28):23368-80. doi: 10.1074/jbc.M112.344671. Epub 2012 May 15.

PMID:
22589544
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss.

Chen Y, Chi P, Rockowitz S, Iaquinta PJ, Shamu T, Shukla S, Gao D, Sirota I, Carver BS, Wongvipat J, Scher HI, Zheng D, Sawyers CL.

Nat Med. 2013 Aug;19(8):1023-9. doi: 10.1038/nm.3216. Epub 2013 Jun 30.

PMID:
23817021
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.

Takayama K, Horie-Inoue K, Ikeda K, Urano T, Murakami K, Hayashizaki Y, Ouchi Y, Inoue S.

Biochem Biophys Res Commun. 2008 Sep 19;374(2):388-93. doi: 10.1016/j.bbrc.2008.07.056. Epub 2008 Jul 18.

PMID:
18640093
[PubMed - indexed for MEDLINE]
16.

ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients.

Baena E, Shao Z, Linn DE, Glass K, Hamblen MJ, Fujiwara Y, Kim J, Nguyen M, Zhang X, Godinho FJ, Bronson RT, Mucci LA, Loda M, Yuan GC, Orkin SH, Li Z.

Genes Dev. 2013 Mar 15;27(6):683-98. doi: 10.1101/gad.211011.112.

PMID:
23512661
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression.

Verras M, Lee J, Xue H, Li TH, Wang Y, Sun Z.

Cancer Res. 2007 Feb 1;67(3):967-75.

PMID:
17283128
[PubMed - indexed for MEDLINE]
Free Article
18.

Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.

Link KA, Balasubramaniam S, Sharma A, Comstock CE, Godoy-Tundidor S, Powers N, Cao KH, Haelens A, Claessens F, Revelo MP, Knudsen KE.

Cancer Res. 2008 Jun 15;68(12):4551-8. doi: 10.1158/0008-5472.CAN-07-6392.

PMID:
18559499
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Conditional expression of the androgen receptor induces oncogenic transformation of the mouse prostate.

Zhu C, Luong R, Zhuo M, Johnson DT, McKenney JK, Cunha GR, Sun Z.

J Biol Chem. 2011 Sep 23;286(38):33478-88. doi: 10.1074/jbc.M111.269894. Epub 2011 Jul 27.

PMID:
21795710
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Anterior gradient 2 and 3--two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells.

Bu H, Schweiger MR, Manke T, Wunderlich A, Timmermann B, Kerick M, Pasqualini L, Shehu E, Fuchsberger C, Cato AC, Klocker H.

FEBS J. 2013 Mar;280(5):1249-66. doi: 10.1111/febs.12118. Epub 2013 Feb 13.

PMID:
23294566
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk